Keyphrases
Enteric Nervous System
100%
Diabetic Gastroparesis
100%
Pathological Changes
66%
Molecular Changes
66%
Histological Examination
66%
Gastric Wall
66%
Interstitial Cells of Cajal
66%
Novel Therapeutic Targets
33%
Fibrosis
33%
Neuron Cells
33%
Morphological Changes
33%
Cellular Components
33%
Stomach
33%
Diabetes Duration
33%
Malnutrition
33%
Muscle Layer
33%
Gastroparesis
33%
Gastric Biopsy
33%
Muscle Cells
33%
Major Components
33%
Molecular Analysis
33%
Neuronal Nitric Oxide Synthase (nNOS)
33%
Nerve Fibers
33%
Control Subjects
33%
Surgical Intervention
33%
Tyrosine Hydroxylase
33%
Full-thickness
33%
Disease-free
33%
Metabolic Control
33%
Severe Symptoms
33%
Hypoglycemic Episodes
33%
Diabetic Ketoacidosis
33%
Lack of Data
33%
PGP9.5
33%
Symptom Onset
33%
Hormonal Influence
33%
C-kit
33%
Vagus
33%
Pathophysiological Basis
33%
Phenotypic Differentiation
33%
Immunohistochemical Examination
33%
Gastric Electrical Stimulation
33%
Abrupt Onset
33%
Heterogeneous Disorder
33%
Refractory Symptoms
33%
Pathological Analysis
33%
Gastric Bypass Surgery
33%
New Analytical Method
33%
Free Area
33%
Poorly Controlled Diabetes
33%
Heme oxygenase-2
33%
Medicine and Dentistry
Intestine Innervation
100%
Diabetic Stomach Paresis
100%
Diabetes
66%
Interstitial Cell of Cajal
66%
Diseases
66%
Morphology
33%
Fibrosis
33%
Antidiabetic Agent
33%
Stomach Paresis
33%
Standing
33%
Metabolic Regulation
33%
Neuronal Nitric Oxide Synthase
33%
Stomach Biopsy
33%
Diabetic Ketoacidosis
33%
Stomach Surgery
33%
Tyrosine 3 Monooxygenase
33%
Heme Oxygenase 2
33%
Nerve Fiber
33%
Biochemistry, Genetics and Molecular Biology
Morphology
100%
Experimental Model
100%
Tyrosine Hydroxylase
100%
Metabolic Regulation
100%
Heme Oxygenase
100%
Intestine Innervation
100%
Standing
100%
Nitric Oxide Synthase
100%
Neuroscience
Staining Technique
100%
Diabetes Mellitus
100%
Enteric Nervous System
100%
Interstitial Cell of Cajal
100%
Neuronal Nitric Oxide Synthase
50%
Nerve Fiber
50%
Tyrosine Hydroxylase
50%
Heme Oxygenase 2
50%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Stomach Paresis
100%
Diseases
66%
Fibrosis
33%
Antidiabetic Agent
33%
Stomach Paresis
33%
Tyrosine 3 Monooxygenase
33%
Neuronal Nitric Oxide Synthase
33%
Diabetic Ketoacidosis
33%
Heme Oxygenase 2
33%